Literature DB >> 7874336

Burn center care for patients with toxic epidermal necrolysis.

J J Kelemen1, W G Cioffi, W F McManus, A D Mason, B A Pruitt.   

Abstract

BACKGROUND: Toxic epidermal necrolysis (TEN) is a life threatening exfoliative disorder that is most commonly precipitated by the administration of a medication. Efforts to reduce morbidity and improve survival have brought into question the use of corticosteroids and recommend the transfer of patients to a burn center to facilitate wound care. STUDY
DESIGN: This study evaluated the correlation of measures of disease severity and impact of treatment strategies on morbidity and mortality in patients with TEN. The records of all patients with TEN admitted to the United States Army Institute of Surgical Research during a 12 year period were reviewed. Patient characteristics, etiologic agents, time to referral of patients to the burn center, corticosteroid therapy, and other demographic features were studied. Univariate and multivariate analyses were used to determine the significance of these factors with respect to outcome.
RESULTS: The sulfonamides and phenytoin were the most frequently identified etiologic agents. Patients at the extremes of age had a higher mortality rate. The period of hospitalization was longer in patients transferred to the burn center more than seven days after skin slough. Percent of epidermalysis, white blood cell count nadir, and corticosteroid administration for more than 48 hours were independently associated with mortality.
CONCLUSIONS: These data indicate that the sulfonamides and phenytoin are the most common etiologic agents, expeditious transfer to a burn center reduces morbidity, and corticosteroid administration dramatically increases mortality.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7874336

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  18 in total

Review 1.  A general overview of burn care.

Authors:  Michel H E Hermans
Journal:  Int Wound J       Date:  2005-09       Impact factor: 3.315

2.  Patient experiences of serious adverse drug reactions and their attitudes to medicines: a qualitative study of survivors of Stevens-Johnson syndrome and toxic epidermal necrolysis in the UK.

Authors:  Tehreem F Butt; Anthony R Cox; Helen Lewis; Robin E Ferner
Journal:  Drug Saf       Date:  2011-04-01       Impact factor: 5.606

3.  Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand.

Authors:  Riichiro Abe; Tadamichi Shimizu; Akihiko Shibaki; Hideki Nakamura; Hirokazu Watanabe; Hiroshi Shimizu
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

4.  New insights in toxic epidermal necrolysis (Lyell's syndrome): clinical considerations, pathobiology and targeted treatments revisited.

Authors:  Philippe Paquet; Gérald E Piérard
Journal:  Drug Saf       Date:  2010-03-01       Impact factor: 5.606

5.  Severe bullous skin diseases: analysis of seven children managed in a burns unit.

Authors:  S Elkharaz; E M Abdel-Razek; A Eldin; A M Abdel-Razek
Journal:  Ann Burns Fire Disasters       Date:  2006-12-31

6.  Therapeutic approach of Lyell syndrome with infliximab and dexamethasone pulse: report of a clinical case.

Authors:  Jânia Dara Jácome Pacheco; Maria Rodrigues Viegas Ribeiro; Catarina Sousa Duque Soares Queirós; Maria Fátima Cameira Martins Xambre
Journal:  An Bras Dermatol       Date:  2022-04-02       Impact factor: 2.113

Review 7.  Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN): could retinoids play a causative role?

Authors:  Anthony R Mawson; Ike Eriator; Sridhar Karre
Journal:  Med Sci Monit       Date:  2015-01-12

8.  Topical clobetasol for the treatment of toxic epidermal necrolysis: study protocol for a randomized controlled trial.

Authors:  Reason Wilken; Chin Shang Li; Victoria R Sharon; Kyoungmi Kim; Falin B Patel; Forum Patel; Emanual Maverakis
Journal:  Trials       Date:  2015-08-22       Impact factor: 2.279

9.  USA: Ophthalmologic Evaluation and Management of Acute Stevens-Johnson Syndrome.

Authors:  Darren G Gregory
Journal:  Front Med (Lausanne)       Date:  2021-07-07

10.  Management of burn injuries--recent developments in resuscitation, infection control and outcomes research.

Authors:  David J Dries
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2009-03-11       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.